Bank Pictet & Cie (Europe)’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$10.8M Buy
160,825
+21,300
+15% +$1.42M 0.21% 72
2026
Q1
$8.76M Sell
139,525
-3,307
-2% -$230K 0.19% 76
2025
Q4
$9.48M Sell
142,832
-8,174
-5% -$528K 0.19% 75
2025
Q3
$10.2M Buy
151,006
+364
+0.2% +$28.8K 0.2% 67
2025
Q2
$13.1M Buy
150,642
+33,067
+28% +$2.59M 0.28% 64
2025
Q1
$8.03M Buy
117,575
+6,512
+6% +$531K 0.19% 71
2024
Q4
$8.64M Buy
111,063
+2,010
+2% +$149K 0.19% 66
2024
Q3
$7.31M Buy
109,053
+24,411
+29% +$2M 0.17% 70
2024
Q2
$9.6M Buy
84,642
+12,318
+17% +$1.56M 0.23% 63
2024
Q1
$10M Buy
72,324
+32,212
+80% +$4.05M 0.26% 68
2023
Q4
$4.98M Sell
40,112
-3,845
-9% -$393K 0.15% 82
2023
Q3
$4.1M Buy
43,957
+39,394
+863% +$4.44M 0.14% 89
2023
Q2
$586K Buy
4,563
+2,210
+94% +$267K 0.02% 167
2023
Q1
$273K Sell
2,353
-1,641
-41% -$184K 0.01% 156
2022
Q4
$452K Sell
3,994
-990
-20% -$109K 0.02% 124
2022
Q3
$401K Hold
4,984
0.02% 127
2022
Q2
$371K Sell
4,984
-2,380
-32% -$217K 0.02% 125
2022
Q1
$942K Buy
7,364
+1,528
+26% +$167K 0.04% 105
2021
Q4
$783K Buy
5,836
+672
+13% +$96.6K 0.03% 112
2021
Q3
$706K Sell
5,164
-17,828
-78% -$2.25M 0.03% 115
2021
Q2
$2.45M Buy
22,992
+1,128
+5% +$108K 0.09% 85
2021
Q1
$1.96M Buy
21,864
+5,976
+38% +$561K 0.08% 90
2020
Q4
$1.47M Buy
+15,888
New +$1.42M 0.07% 85
2018
Q2
Sell
-20,868
Closed -$387K 152
2018
Q1
$387K Buy
20,868
+2,348
+13% +$34.7K 0.06% 129
2017
Q4
$266K Buy
+18,520
New +$241K 0.04% 151

Other funds holding DXCM

Bank Pictet & Cie (Europe)'s DXCM Position: Q2 2026 in Review

Bank Pictet & Cie (Europe) increased its DexCom (DXCM) stake by 15% in Q2 2026, buying an estimated $1.42M and bringing the position to 160,825 shares worth $10.8M. The position accounts for 0.21% of the portfolio, ranked #72.

Bank Pictet & Cie (Europe) first reported a position in DXCM in Q4 2017 and has held it in 25 quarters since. The position peaked at $13.1M in Q2 2025. 496 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • Bank Pictet & Cie (Europe) held 160,825 shares of DexCom worth $10.8M as of Q2 2026.
  • Bank Pictet & Cie (Europe) bought 21,300 DexCom shares in Q2 2026, an estimated $1.42M.
  • DexCom made up 0.21% of Bank Pictet & Cie (Europe)'s portfolio in Q2 2026, its #72 holding.
  • Bank Pictet & Cie (Europe) first reported a position in DexCom in Q4 2017 and has held it in 25 quarters since.
  • Bank Pictet & Cie (Europe)'s DexCom position peaked at $13.1M in Q2 2025.
  • 496 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on Bank Pictet & Cie (Europe)'s 13F filing for Q2 2026, filed 24 Jul 2026.